DNAJB2 and Parkinson disease: Recent literature has also suggested an association between DNAjB2 variants and neurodegenerative disorders such as Parkinson's disease (PD).<h4>Design/methods</h4>Case Report.<h4>Case description</h4>We present a 36-year-old female patient initially diagnosed with CMT2 at the age of 28, who later developed symptoms of PD in her fourth decade.